In the same cells, 20 μM resveratrol reduced the expression of PCSK9 and promoted LDL uptake, with important implications for the pathogenesis of non-alcoholic fatty liver disease (NAFLD), the leading cause of liver damage [100]. Here, PCSK9 is linked to metabolic dysfunction-associated steatotic liver disease.